Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Wharf Rat who wrote (1563173)	10/5/2025 6:37:48 PM
From: maceng2	1 Recommendation Recommended By longz Read Replies (1) \| Respond to of 1577023

Since when has the field of specialization made any difference to your blinkered view? Here is Dalgleish's details. Awards and honours Dalgleish was elected a Fellow of the Academy of Medical Sciences in 2001 [2] and is also a Fellow of the Royal College of Physicians[ when?] the Royal College of Pathologists[ when?] and a Fellow of the Royal Australasian College of Physicians.[ when?] [24] His citation on election to FMedSci reads: Professor Angus Dalgleish is Professor of Oncology at St Georges Hospital Medical School London. He has made seminal observations relating to the virology of HIV. In particular he identified CD4 as a major receptive for HIV in humans, produced the first report of a link between Slim Disease in Africa and HIV infection. He also identified the close correlation between the immune response and the presence of tropical spastic paraparesis in patients infected with the HTLV-1 virus. [2]